Takeda Pharmaceutical Company Limited Adjustments For Decrease Increase In Inventories
Takeda Pharmaceutical Company Limited (TAK) reported Adjustments For Decrease Increase In Inventories of -JPY 34.97 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes › Inventory
ifrs-full:AdjustmentsForDecreaseIncreaseInInventories · last filed 2025-06-25
| Period end | Adjustments For Decrease Increase In Inventories 12 month | Adjustments For Decrease Increase In Inventories 12 month as first filed |
|---|---|---|
| 2025-03-31 | -34.97B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | -115.74B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | -79.16B JPY 20-F · filed 2025-06-25 | |
| 2022-03-31 | -46.15B JPY 20-F · filed 2024-06-26 | |
| 2021-03-31 | 25.98B JPY 20-F · filed 2023-06-28 | |
| 2020-03-31 | 137.49B JPY 20-F · filed 2022-06-29 | |
| 2019-03-31 | 50.72B JPY 20-F · filed 2021-06-29 | 58.68B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 13.72B JPY 20-F · filed 2020-06-24 | |
| 2017-03-31 | 3.89B JPY 20-F · filed 2019-06-27 |